Dennis L. Andress

Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease

Bryan Kestenbaum, Joshua N. Sampson, Kyle Rudser et al. · Journal of the American Society of Nephrology · 2004 · 1.2K citations

Hemodialysis, Urology, Renal Disease +14

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl et al. · The Lancet · 2010 · 686 citations

Renal Function, Vital Study, Diabetes +4

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease

Ravi Thadhani, Evan Appelbaum, Yili Pritchett et al. · JAMA · 2012 · 548 citations

The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy

Dick de Zeeuw, Blai Coll, Dennis L. Andress et al. · Journal of the American Society of Nephrology · 2014 · 290 citations · Full text

Hypertension, Adverse Events, Residual Albuminuria +11